Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.
CytoDyn Inc. (OTC: CYDY) CEO Interview with Nader Pourhassan, Ph.D, providing an update on the company’s drug development pipeline targeting HIV and cancers, based on CytoDyn’s Leronlimab/PRO 140 platform. […]
MassRoots, Inc. (OTC: MSRT) Interview with CEO, Isaac Dietrich discussing the company’s services to the cannabis industry. Discussion includes: MassRoots app and WeedPass market progress, and the COWA […]
The Green Organic Dutchman (TSX: TGOD) Investor Presentation Did you enjoy this article? Join our FREE Newsletter! Thank you for subscribing. Something went wrong. I agree to have my personal information transfered to MailChimp ( […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
